Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
471. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979; 76: 771-81.<br />
472. Mitchison DA, Dickinson JM. Laboratory aspects of intermittent drug therapy.<br />
Postgrad Med J 1971; 47: 737-41.<br />
473. Hill AB. Memories of the British streptomycin trial in tuberculosis. The first<br />
r<strong>and</strong>omized clinical trial. Contr Clin Trials 1990; 11: 77-9.<br />
474. D’Arcy Hart P. A change in scientific approach: from alteration to r<strong>and</strong>omised<br />
allocation in clinical trials in the 1940s. BMJ 1999; 319: 572-3.<br />
475. Iseman MD, Sbarbaro JA. Short-course chemotherapy of tuberculosis. Hail<br />
Britannia (<strong>and</strong> friends). Editorial. Am Rev Respir Dis 1991; 143: 697-8.<br />
476. O’Brien RJ, Vernon AA. New tuberculosis drug development. How can we do<br />
better? (Editorial). Am J Respir Crit Care Med 1998; 157: 1705-7.<br />
477. Crofton J. “Sputum conversion” <strong>and</strong> the metabolism of isoniazid.<br />
(Correspondence). Am Rev Tuberc Pulm Dis 1958; 77: 869-71.<br />
478. Crofton J. Chemotherapy of pulmonary tuberculosis. BMJ 1959; 1: 1610-4.<br />
479. Ferebee SH, Theodore A, Mount FW. Long-term consequences of isoniazid alone<br />
as initial therapy. United States Public Health Service <strong>Tuberculosis</strong> Therapy<br />
Trials. Am Rev Respir Dis 1960; 82: 824-30.<br />
480. Ferebee SH. The effect of streptomycin on the emergence of bacterial resistance<br />
to isoniazid. A United States Public Health Service Cooperative Investigation.<br />
Am Rev Tuberc 1953; 67: 553-67.<br />
481. Mount FW, Ferebee SH. <strong>Control</strong> study of comparative efficacy of isoniazid,<br />
streptomycin - isoniazid, <strong>and</strong> streptomycin - para-aminosalicylic acid in pulmonary<br />
tuberculosis therapy. IV. Report on <strong>for</strong>ty-week observations on 583 patients with<br />
streptomycin-susceptible infections. Am Rev Tuberc 1953; 68:264-9.<br />
482. Mount FW, Ferebee SH. United States Public Health Service Cooperative<br />
Investigation of antimicrobial therapy of tuberculosis. V. Report of thirty-twoweek<br />
observations on combinations of isoniazid, streptomycin, <strong>and</strong> para-aminosalicylic<br />
acid. Am Rev Tuberc 1954; 70: 521-6.<br />
483. Mount FW, Ferebee SH. Sequential use of paired combinations of isoniazid, streptomycin,<br />
para-aminosalicylic acid, <strong>and</strong> pyrazinamide. A United States Public Health<br />
Service tuberculosis therapy trial. Am Rev Respir Dis 1959; 80: 627-40.<br />
484. Doster B, Murray FJ, Newman R, Woolpert SF. Ethambutol in the initial treatment<br />
of pulmonary tuberculosis. Am Rev Respir Dis 1973; 107: 177-90.<br />
485. Doster B, Newman R. Ethambutol in re-treatment of pulmonary tuberculosis.<br />
United States Public Helath Service tuberculosis therapy trial.<br />
Dis 1968; 98: 825-36.<br />
Am Rev Respir<br />
486. Newman R, Doster B, Murray FJ, Woolpert SF. Rifampin in initial treatment<br />
of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy<br />
trial. Am Rev Respir Dis 1974; 109: 216-32.<br />
200
Change language